{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:38:08Z","timestamp":1794476288654,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.vaccine.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T14:20:04Z","timestamp":1118931604000},"page":"5091-5098","source":"Crossref","is-referenced-by-count":32,"title":["Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives"],"prefix":"10.1016","volume":"23","author":[{"given":"Carmen","family":"Arigita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Luijkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martien","family":"Poelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.A.","family":"Crommelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter van der","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile van","family":"Els","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon F.A.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.06.001_bib1","doi-asserted-by":"crossref","unstructured":"Cartwright K, Noah N, Peltola H. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6\u20138 October 2000. Vaccine 2001;29:4347\u20134356.","DOI":"10.1016\/S0264-410X(01)00205-5"},{"key":"10.1016\/j.vaccine.2005.06.001_bib2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.06.001_bib3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.06.001_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib5","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Annals"},{"key":"10.1016\/j.vaccine.2005.06.001_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","article-title":"Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the PorA genes for use in the production of a multivalent vesicle vaccine","volume":"13","author":"van der Ley","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib7","first-page":"195","article-title":"Vaccines against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra GVG","year":"1991","journal-title":"NIPH Annals"},{"key":"10.1016\/j.vaccine.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(00)00320-0","article-title":"Immunogenicity and safety of monovalent p1.7(h), 4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations","volume":"19","author":"de Kleijn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"de Kleijn","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"Arigita","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nature Biotech"},{"key":"10.1016\/j.vaccine.2005.06.001_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis LpxL mutants: influence of lipoplysaccharide structure, toxicity and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.06.001_bib15","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0966-842X(02)02426-5","article-title":"Taking toll: lipid A mimetics as adjuvants and immunomodulators","volume":"10","author":"Persing","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0171-2985(11)80355-4","article-title":"Lipopolysaccharide, lipid A and liposomes containing lipid A as immunologic adjuvants","volume":"187","author":"Alving","year":"1993","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/meth.1999.0834","article-title":"Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines","volume":"19","author":"Baldridge","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2005.06.001_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2958.1993.tb01962.x","article-title":"Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis","volume":"10","author":"Jennings","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.06.001_bib19","first-page":"83","article-title":"Bacterial lipopolysaccharide extraction by phenol\u2013water and further application of the procedure","volume":"5","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"key":"10.1016\/j.vaccine.2005.06.001_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01960070","article-title":"Preparation of liposomes via detergent removal from mixed micelles by dilution: the effect of bilayer composition and process parameters on liposomes characteristics","volume":"8","author":"Jiskoot","year":"1986","journal-title":"Pharmaceutisch Weekblad Sci Ed"},{"key":"10.1016\/j.vaccine.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","article-title":"A simplification of the protein assay of Lowry et al. which is more generally applicable","volume":"83","author":"Peterson","year":"1977","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02531316","article-title":"Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots","volume":"5","author":"Rouser","year":"1970","journal-title":"Lipids"},{"key":"10.1016\/j.vaccine.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2003.08.027","article-title":"Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines","volume":"22","author":"Arigita","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0005-2736(00)00155-3","article-title":"Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis","volume":"1464","author":"Jansen","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2005.06.001_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1574-6968.1987.tb02626.x","article-title":"Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies","volume":"48","author":"Abdillahi","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2005.06.001_bib26","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1128\/IAI.63.9.3473-3478.1995","article-title":"Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis","volume":"63","author":"Hoogerhout","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CDLI.10.1.133-139.2003","article-title":"Simultaneous detection of 15 human cytokines in a single sample of stimulated peripherial blood mononuclear cells","volume":"10","author":"de Jager","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.06.001_bib28","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0264-410X(01)00193-1","article-title":"Towards the rational design of Th1 adjuvants","volume":"19","author":"Moingeon","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"O\u2019Hagan","year":"2001","journal-title":"Biomol Eng"},{"key":"10.1016\/j.vaccine.2005.06.001_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2776(08)60652-5","article-title":"Heterogeneity of cytokine secretion patterns and functions of T helper cells","volume":"46","author":"Mosmann","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2005.06.001_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0264-410X(98)00259-X","article-title":"Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine","volume":"17","author":"Naess","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.001_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"Neisseria meningitidis serogroup B: laboratory correlates of protection","volume":"34","author":"Vermont","year":"2002","journal-title":"FEMS Immun Med Microb"},{"key":"10.1016\/j.vaccine.2005.06.001_bib34","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1128\/IAI.67.10.4988-4993.1999","article-title":"Immunogenicity of outer membrane protein in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response","volume":"67","author":"Steeghs","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.06.001_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/mpat.1996.0079","article-title":"Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response","volume":"21","author":"Ward","year":"1996","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.06.001_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.168.2.926","article-title":"Monophosphoryl lipid A activates both human dendritic cells and T cells","volume":"168","author":"Ismaili","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.06.001_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/IAI.66.3.959-965.1998","article-title":"Human T-cell responses after vaccination with the Norwegian group B Meningococcal outer membrane vesicle vaccine","volume":"66","author":"Naess","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.06.001_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni0603-503","article-title":"TH1\u2013TH2: a procrustean paradigm","volume":"4","author":"Gor","year":"2003","journal-title":"Nature Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05005670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05005670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:34:16Z","timestamp":1586288056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05005670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":38,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0264410X05005670"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.06.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}